SAN MATEO, Calif.--(BUSINESS WIRE)--Deltagen, Inc. (Pink Sheets:DGEN), a leading provider of drug discovery tools to the biopharmaceutical industry, today reported audited financial results for the year ended December 31, 2006 and declared a 5-cent per share dividend scheduled to be distributed on or about May 31, 2007 to shareholders of record as of the close of business on May 21, 2007.
